Understanding blood sugar levels during pregnancy and their effects on outcomes
Glycemic Profiles and Pregnancy Outcomes Study (GLOSS)
This study is looking at how using continuous glucose monitors can help pregnant women, especially those at risk for gestational diabetes, by tracking their blood sugar levels to spot any changes early on and improve health for both moms and babies.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11167411 on NIH RePORTER |
What this research studies
This research investigates how continuous glucose monitoring (CGM) can provide insights into blood sugar levels in pregnant women, particularly those at risk for gestational diabetes mellitus (GDM). By tracking glucose levels throughout pregnancy, the study aims to identify patterns and changes that could help in diagnosing and managing GDM earlier, potentially improving outcomes for both mothers and their children. The approach involves collecting and analyzing data from CGM devices to understand the relationship between glycemic profiles and pregnancy outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant women, particularly those in their first trimester or at risk for developing gestational diabetes.
Not a fit: Patients who are not pregnant or those who do not have risk factors for gestational diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and better management of gestational diabetes, reducing risks for mothers and their babies.
How similar studies have performed: Other research has shown promise in using continuous glucose monitoring for managing diabetes, suggesting that this approach could be beneficial in the context of pregnancy as well.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Yee, Lynn M — Northwestern University at Chicago
- Study coordinator: Yee, Lynn M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.